Publications by authors named "Pere Gascon"

Claim this Profile
E
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer.
Joaquim Bosch-Barrera, Purificación Estévez-García, Paloma Martín-Martorell, Renaud Sabatier, Ernest Nadal

Lung Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma.
Núria Moragas, Patricia Fernandez-Nogueira, Leire Recalde-Percaz, Jamie L Inman, Anna López-Plana

Breast Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer.
Alexandra Leary, Purificación Estévez-García, Renaud Sabatier, Isabelle Ray-Coquard, Margarita Romeo

BMC Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer : Alexandra Leary.
Alexandra Leary, Purificación Estévez-García, Renaud Sabatier, Isabelle Ray-Coquard, Margarita Romeo

BMC Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment : An expert view.
Pere Gascón, Ahmad Awada, Peeter Karihtala, Sylvie Lorenzen, Christoph Minichsdorfer

Wien Klin Wochenschr· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filgrastim biosimilar (EP2006): A review of 15 years' post-approval evidence.
Pere Gascón, Nadia Harbeck, Bernardo L Rapoport, Ronald Anderson, Ines Brueckmann

Crit Rev Oncol Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Imaging Detected Silent Male Breast Cancer in Autopsy Specimens: Study of the Disease Held by Image-Guided Biopsies.
Zacharoula Sidiropoulou, Ana Paula Vasconcelos, Cristiana Couceiro, Carlos Dos Santos, Ana Virginia Araújo, Pere Gascon

Acad Forensic Pathol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa biosimilar (HX575): A review of 15 years' post-approval clinical experience.
Pere Gascón, David Goldsmith, Matti Aapro, Frank Dellanna, Altaher Esmael

Crit Rev Oncol Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Imaging-Detected Silent Female Breast Cancer in Autopsy Specimens: A Study Using Image-Guided Biopsies.
Zacharoula Sidiropoulou, Ana Vasconcelos, Cristiana Couceiro, Carlos Santos, Ana Virginia Araujo

Cureus· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications.
Carlos Camps, Rafael López, Antonio Antón, Enrique Aranda, Alfredo Carrato

JCO Oncol Pract· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence.
Marta Gabasa, Evette S Radisky, Rafael Ikemori, Giulia Bertolini, Marselina Arshakyan

Cancer Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis.
Patricia Fernández-Nogueira, Gemma Fuster, Álvaro Gutierrez-Uzquiza, Pere Gascón, Neus Carbó

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours.
Laura Vidal, Ivan Victoria, Lydia Gaba, Marta Gil Martín, Mercè Brunet

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving awareness of several combination therapies for acute myeloid leukemia among oncology and hematology team members in Colorado, USA.
Rovshan M Ismailov, Dyana T Saenz, Pere Gascon, Marcio Nucci, Zaytuna D Khasanova

Hematol Transfus Cell Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression.
Paloma Bragado, Patricia Fernández-Nogueira, Neus Carbó, Pere Gascón

Oncotarget· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
Anna López-Plana, Patricia Fernández-Nogueira, Pau Muñoz-Guardiola, Sònia Solé-Sánchez, Elisabet Megías-Roda, Pere Gascon

Int J Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables Cure.
Paul Cornes, Pere Gascon, Arnold G Vulto, Matti Aapro

BioDrugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, Anna López-Plana, Patricia Jauregui, Pere Gascon

Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy.
Patricia Fernández-Nogueira, Mario Mancino, Gemma Fuster, Paloma Bragado, Miquel Prats de Puig

J Clin Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC.
Pere Gascón, Rajnish Nagarkar, Martin Šmakal, Konstantinos N Syrigos, Carlos H Barrios

J Thorac Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Repression in Tumor-Associated Fibroblasts Impairs Fibrosis and Response to the Antifibrotic Drug Nintedanib in Lung Squamous Cell Carcinoma.
Rafael Ikemori, Marta Gabasa, Paula Duch, Miguel Vizoso, Paloma Bragado, Pere Gascon

Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim.
Pere Gascon, Andriy Krendyukov, Nicola Mathieson, Maja Natek, Matti Aapro

BioDrugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge and awareness of biosimilars among oncology patients in Colorado, USA.
Rovshan M Ismailov, Zaytuna D Khasanova, Pere Gascon

Future Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts.
Carlos Camps Herrero, Antonio Antón Torres, Juan Jesús Cruz-Hernández, Alfredo Carrato, Manuel Constenla

J Pain Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa for the treatment of myelodysplastic syndrome-related anemia: A review of clinical data, clinical guidelines, and treatment protocols.
Pere Gascón, Andriy Krendyukov, Nicola Mathieson, Matti Aapro

Leuk Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis